LAPACT: An open-label, multicenter phase II trial of nab-paclitaxel (nab-P) plus gemcitabine (Gem) in patients (pts) with locally advanced pancreatic cancer (LAPC).

Affiliation auteurs!!!! Error affiliation !!!!
TitreLAPACT: An open-label, multicenter phase II trial of nab-paclitaxel (nab-P) plus gemcitabine (Gem) in patients (pts) with locally advanced pancreatic cancer (LAPC).
Type de publicationJournal Article
Year of Publication2016
AuteursPhilip PAgop, Lacy J, Dowden SD, Sastre J, Bathini VGopal, Cardin DBacklund, Ma WWee, Sobrero AF, Koski SL, Borg C, Tonini G, Rivera F, Hwang JJ, Knoble JL, Baghdadi TAl, Saif WM, Meiri E, Kayitalire L, Li J, Hammel P
JournalJOURNAL OF CLINICAL ONCOLOGY
Volume34
Date PublishedFEB 1
Type of ArticleMeeting Abstract
ISSN0732-183X
DOI10.1200/jco.2016.34.4_suppl.tps477